Zhonglei Wang

发表

Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery

Xian-En Zhao, Zhonglei Wang, Liyan Yang, 2021, Computational and Structural Biotechnology Journal.

Advances in the Asymmetric Total Synthesis of Natural Products Using Chiral Secondary Amine Catalyzed Reactions of α,β-Unsaturated Aldehydes

Zhonglei Wang, 2019, Molecules.

Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue

Zhonglei Wang, Liyan Yang, 2022, Frontiers in Public Health.

Broad‐spectrum prodrugs with anti‐SARS‐CoV‐2 activities: Strategies, benefits, and challenges

Zhonglei Wang, Liyan Yang, 2021, Journal of medical virology.

Dietary Restriction against Parkinson’s Disease: What We Know So Far

Haiyang Yu, L. Wen, Xin He, 2022, Nutrients.

Synthesis and Anti-hypertensive Effects of the Twin Drug of Nicotinic Acid and Quercetin Tetramethyl Ether

Zhonglei Wang, Liyan Yang, Shuai Cui, 2014, Molecules.

Bioactive natural products in COVID-19 therapy

Zhonglei Wang, Liyan Yang, Ning Wang, 2022, Frontiers in Pharmacology.

Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase

Zhonglei Wang, Liyan Yang, Xianchuan Song, 2022, Frontiers in Immunology.

Organocatalytic enantioselective direct alkylation of phloroglucinol derivatives: asymmetric total synthesis of (+)-aflatoxin B2.

L. Zu, Zhonglei Wang, 2019, Chemical communications.

GS-5734: a potentially approved drug by FDA against SARS-Cov-2

Zhonglei Wang, Liyan Yang, 2020 .

Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection

Zhonglei Wang, Liyan Yang, 2020, Frontiers in Pharmacology.

[3 + 2] Annulations between indoles and α,β-unsaturated ketones: access to pyrrolo[1,2-a]indoles and model reactions toward the originally assigned structure of yuremamine

L. Zu, Haokun Li, Zhonglei Wang, 2015 .

Total Synthesis of (±)-Grandilodine B.

L. Zu, Xiaotong Yao, Xiaoni Xie, 2017, Organic letters.

Advances in the Chemical Synthesis of Artemisinin

X. Yang, Zhonglei Wang, Liyan Yang, 2014 .

[3 + 2] Annulations Between Indoles and α,β-Unsaturated Ketones: Access to Pyrrolo[1,2-a]indoles and Model Reactions Toward the Originally Assigned Structure of Yuremamine.

L. Zu, Haokun Li, Zhonglei Wang, 2015 .

Advances in the First Total Synthesis of Natural Flavonoids

X. Yang, Zhonglei Wang, Liyan Yang, 2013 .

Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts

Zhonglei Wang, Liyan Yang, 2021, Journal of Ethnopharmacology.

Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer

Zhonglei Wang, Liyan Yang, 2021, Biomedicines.

Advances in the Total Synthesis of Aflatoxins

Zhonglei Wang, Liyan Yang, 2021, Frontiers in Chemistry.

In the age of Omicron variant: Paxlovid raises new hopes of COVID‐19 recovery

Zhonglei Wang, Liyan Yang, 2021, Journal of medical virology.

Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China

Zhonglei Wang, Liyan Yang, 2023, European journal of medicinal chemistry.

Advances in the Chemical Synthesis of Artemisinin

Liyan Yang, Xiu-Wei Yang, Zhonglei Wang, 2014 .

Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China

Zhonglei Wang, Liyan Yang, 2023, European Journal of Medicinal Chemistry.

Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology

A. Tariq, Zhonglei Wang, Lin Li, 2023, Arabian Journal of Chemistry.

The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection

Zhonglei Wang, Liyan Yang, 2023, Nutrients.

Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Zhonglei Wang, Liyan Yang, Xian-qing Song, 2023, Nutrients.

Natural-product-based, Carrier-free, Noncovalent Nanoparticles for Tumor Chemo-photodynamic Combination Therapy.

Zhonglei Wang, Liyan Yang, 2024, Pharmacological research.

An activatable, carrier-free, triple-combination nanomedicine for ALK/EGFR-mutant non-small cell lung cancer high-permeable targeted chemotherapy

Peiwei Gong, Yake Li, Zhonglei Wang, 2022, New Journal of Chemistry.

A computer-aided, heterodimer-based "triadic" carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency.

Zhonglei Wang, Liyan Yang, Wenjing Xu, 2024, Journal of colloid and interface science.